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there is an abundance of candidate genes in the PKD1 interval
that encode proteins with functions that may play a role in
regulating cell growth, cell fate determination, and intracellular
protein sorting mechanisms. One of these, tuberin encodes a
GTPase that functions as a growth suppressor gene and is
mutated in 30% of all cases of tuberous sclerosis (TSC2). Angio-
myolipomas are the most common renal manifestation of this
disease, but renal cystic disease indistinguishable by ultrasonog-
raphy from that of ADPKD is also observed. Although it is
unlikely that the mutations of tuberin causes PKD1, a survey of
the list of candidates and their probable functions suggests a
clustering of genes with potentially complementary functions that
may be important for normal renal morphogenesis and function.
The discovery of abnormal expression in cystic kidneys of an
additional two novel genes whose functions are unknown further
supports this hypothesis. It would appear that there are an
overabundance of good candidates based on putative functions
and expression patterns.
The absence of clues to the identity of the PKD1 gene has
necessitated the use of laborious sequence-based techniques such
as direct genomic sequencing and single-strand conformational
analysis (SSCA). The search for PKD1 is uniquely complicated,
however, by the clustering of more than 20 candidate genes
encoding more than 60 kb of mRNA. The gene for cystic fibrosis,
CFTR, is the only example of a disease gene identified strictly on
the basis of oligo-base pair sequence abnormalities detected using
sequence-based approaches. CFTR was only one of a handful of
possible candidates for cystic fibrosis, and its genomic organiza-
tion strongly implicated it as a leading candidate.
A final unique feature of the PKD1 gene hunt is the extraor-
dinary complexity of the leading candidate gene, KG8. The gene
encodes a very large mRNA and maps adjacent to tuberin. The
latter observation is significant because it is possible that renal
cysts develop in the subset of patients with TSC2 that have
deletions which include nearby genes. Cloned cDNA fragments of
KG8 detect several mRNA species, the most common of which is
more than 12 kb in length and present in increased quantities in
cystic kidneys. Genomic analysis has revealed a bipartite structure
with a PKD1 locus-specific 3'-end and a 5' portion replicated in
multiple copies elsewhere on chromosome 16. Both intronic and
exonic sequences are conserved within this novel gene family. The
very high sequence similarity has greatly complicated the search
for mutations. Thus, we have developed gene product-base meth-
ods as a complementary approach. We hypothesize that disease-
producing mutations must somehow alter the protein product in
either quantitative of qualitative manner. These differences may
be detectable by either ID or 2D immunoblot analysis or by
immunolocalization studies. Antibodies generated against the 3'
PKD1-locus specific portion of the KG8 protein will be useful in
analyzing the protein product encoded by the PKD1 member of
this family.
In summary, there has been great progress in narrowing the size
of the genetic interval and isolating candidate genes. Major
obstacles to gene discovery have been the absence of clinical or
molecular clues, the large number of genes and the length of their
mRNA, and the replicated nature of a leading candidate. Several
complementary approaches are being employed to expedite gene
discovery: (a) molecular analysis of individuals with tuberous
sclerosis and renal cystic disease; (d) SSCA and direct genomic
sequencing of candidate genes; (c) characterization of proteins
encoded by candidate genes in the tissues of affected individuals.
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Genetic heterogeneity in medullary cystic kidney disease
C. Antignac
Hôpital Necker-Enfants Malades, Paris, France
Familial juvenile nephronophthisis (NPH) or recessive medul-
lary cystic kidney disease is an autosomal recessive kidney disor-
der. It is the most frequent genetic cause of end-stage renal
disease (ESRD) in childhood, accounting for 6% to 10% of
ESRD in children in Europe. NPH is characterized by chronic
tubulointerstitial nephritis and the presence of cysts in the me-
dulla, the latter being a late manifestation of the disease. The
early tubular basement membrane (TBM) abnormalities and the
inability to label the TBM with certain anti-TBM autoantibodies
suggest that the fundamental defect in NPH might be the produc-
tion of an abnormal TBM. However, the biochemical defect is
unknown. A number of heterogeneous extra-renal abnormalities
have been described associated and segregating with this renal
disease. The most frequent is Leber amaurosis, characterized by
blindness in early infancy, occuring in 16% of the cases of NPH.
The subtype of NPH associated with Leber amaurosis is described
as Senior-Loken syndrome (SLS). Later onset with progressive
visual defect has also been reported. Occasionally, other abnor-
malities (cerebellar dysfunction, liver involvement or bone anom-
alies) have been described in association with the renal and ocular
symptoms.
We have previously shown that the purely renal form of NPH
maps to chromosome 2, since we obtained a significant lod score
of 4.79 at 0 = 0.058 at the locus D2S160 in 18 kindreds with NPH.
In contrast, the lod score in four families with SLS excluded up
to 9% recombination with this marker. These results, further
strengthened by heterogeneity tests, suggested genetic heteroge-
neity between NPH and SLS. Other researchers have recently
confirmed these results in 9 German families with NPH.
To map this NPH gene more precisely, we have now tested the
segregation of 6 new microsatellite markers and 5 additional
families. Haplotype analysis show uneqivocally that 4 NPH fam-
ilies are not linked to the chromosome 2 markers, although there
is no clinical or pathological feature discernible in these families
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that could separate them from the families linked to the chromo-
some 2 NPH locus (named NPH1). This reveals genetic hetero-
geneity also in the purely renal form of NPH. In situ hybridization
of YAC clones isolated with 2 closely linked markers assigned the
NPH1 regions to 2q13. Futhermore, based on haplotype analysis
and specific recombination events, the NPH1 gene has been
placed between D2S293/D2S340 and D2S121, a genetic interval of
about 5 to 7 CM.
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Role of modifier genes in PKD
E.H. Birkenmeier and P. Janaswami
The Jackson Laboratoiy, Bar Harbor, Maine, USA
We are studying a new spontaneous mutation, nm1633, that is
an autosomal recessive located on mouse Chromosome 8. Mice
homozygous for the mutated allele are runts during the suckling
period and manifest an unusual facial dysmorphism at the time of
weaning. After weaning, the testes fail to develop normally and
undergo degenerative changes resulting in male sterility. The
kidneys develop a progressive polycystic disease with a pathology
remarkably similar to human autosomal dominant PKD. The
nm1633 mutation occurred on the C57BL/6J inbred strain. On
this genetic background, renal cysts grow at a remarkable constant
rate during the first year of life with the wet weight of the kidneys
doubling eveiy 120 days. Affected animals that survive weaning
appear to die of renal failure at 8 to 12 months of age, and males
live slightly longer than females.
During our initial genetic studies, we used a linkage testing
stock, MeviTy, to determine the chromosomal location of the
nm1633 mutation. Initial difficulties occurred when we were
unable to identify mutant animals in the F2 generation using the
criteria of decreased body size and the presence of a readily
apparent facial dysmorphism at weaning. Gross examination of
the kidneys at 6 to 8 weeks of age also failed to reveal the presence
of cysts. Since renal cysts were readily apparent at this age in
C57BL/6J mice, we concluded that genetic background had a
dramatic affect on the rate of cyst growth. We were eventually able
to map the nml 633 mutation to Chromosome 8 by waiting until
the F2 animals reached 10 months of age when histological
examination of the kidneys confirmed the presence of cystic
disease in approximately 25% of the mice.
Next, we generated an intercross between nm1633-C57BL/6J
and an inbred strain of Mus castaneus, CASTIEi. Because of the
relatively large genetic variation between these two species of
mice, we reasoned it would be easier to fine map the nml 633
mutation on Chromosome 8 in preparation of positional cloning
of the locus. Similarly, scanning the genome for the presence of
modifier genes would also be facilitated with this genetic cross.
Using simple sequence length polymorphisms (SSLPs) and the
(C57BL/6J X CAST/Ei)F1 intercross, nm1633 was fine mapped
on Chromosome 8 and a yeast artificial chromosome (YAC)
contiguous of the region is now almost complete.
Surprisingly, the average rate of cyst growth in the CAST/Ei
intercross was increased rather that decreased as observed with
MeviTy. To map the CASTIEi modifier gene allele responsible for
the increase severity of cystic disease, we scanned the genome of
43 mutant F2 mice using 3 to 6 SSLPs per chromosome. Analysis
of the log wet kidney weight at 6 months of age and the genotype
of all loci examined using MAPMAKER/QTL, identified a mod-
ffier gene on distal mouse Chromosome 19 near Dl9Mitl (LOD
score 3.11) that was responsible for a significant amount (30% to
50%) of the variation of cystic disease observed in the F2 animals.
A second method used to attempt cloning the nm1633 mutation
and possibly identify modifier genes was differential screening of
a mouse kidney cDNA library using radiolabeled cDNA probes
from normal and mutant C57BL/6J mice. Two clones (nm1633A
and nm1633B) were identified that showed three- to fourfold
reduced expression in the mutant kidney. The nm1633B clone
mapped to distal Chromosome 6 near Kap which encodes the
androgen-inducible protein, KAP. DNA sequence analysis con-
firmed that nm1633B was KAP. Interestingly, Calvet and co-
workers have reported reduced expression of KAP in mice with
congenital polycystic kidney disease, cpk, a mutation that maps to
proximal Chromosome 12.
DNA sequence analysis of the nm1633A cDNA also generated
unexpected results. The DNA sequence was strongly related to
the DNA sequence of a human SA protein cDNA clone. The SA
protein was originally identified in the kidney of hypertensive
SHR rats because expression was increased approximately tenfold
over the observed in WKY normotensive rats. For this reason, SA
protein gene is considered a candidate gene affecting severity of
essential hypertension in rats. Our protein database searches for
other amino acid sequences related to both nm1633B and the SA
protein also yielded surprising results. The MACAW protein
sequence alignment program showed that both genes are mem-
bers of a super-gene family of enzymes that bind AlP and
adenylate substrates as part of a two-step mechanism that even-
tually generates AMP and PPi as end products.
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